MAL23076004ACRZPrescription (MAL-A)

Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules

Generic Molecule: Mometasone Furoate

ACTIVE & APPROVEDValid till: 6 Jul 2028
NPRA Official Regulatory Summary

Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules is a KKM-approved Prescription Medicine registered under MAL number MAL23076004ACRZ by NOVARTIS CORPORATION (MALAYSIA) SDN. BHD.. Its active ingredient is Mometasone furoate 0.080 mg, Indacaterol acetate 0.173 mg, Glycopyyronium bromide 0.063 mg, manufactured by Siegfried Barbera, S.L..

Holder (PRH)
NOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Manufacturer
Siegfried Barbera, S.L.
First Registered
6 Jul 2023
Validity
6 Jul 2028

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

3 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
Mometasone furoate0.080 mgFind Brands
Indacaterol acetate0.173 mgFind Brands
Glycopyyronium bromide0.063 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL23076004ACRZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules approved by KKM / NPRA?

Yes. Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL23076004ACRZ with current status PRODUCT APPROVED. Registration was filed by NOVARTIS CORPORATION (MALAYSIA) SDN. BHD..

What are the active ingredients of Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules?

The declared active therapeutic components are: Mometasone furoate 0.080 mg, Indacaterol acetate 0.173 mg, Glycopyyronium bromide 0.063 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 16 registered brand formulations containing identical active ingredients (Mometasone Furoate). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Enerzair Breezhaler (Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate) 150/50/80mcg Inhalation Powder Hard Capsules (MAL23076004ACRZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.